Zhaoxia Kang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zhaoxia Kang has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Dan Wang
Chongqing Medical University College of Traditional Chinese Medicine Chongqing China
1 shared publication Daye Yang
Hubei University of Chinese Medicine Wuhan China
1 shared publicationDongmei Cui
Guizhou University of Traditional Chinese Medicine, Guiyang, China
1 shared publication- Hongxing Zhang
Jianghan University Institute of Acupuncture and Moxibustion, Wuhan, China
1 shared publication Jia Li
Hubei University of Chinese Medicine Wuhan China
1 shared publicationJinling Zhang
Institute of Acupuncture and Moxibustion China Academy of Chinese Medical Sciences Beijing China
1 shared publication
Latest Publications
- 22 February 2025
- Published by Springer Nature in Journal of Acupuncture and Tuina Science
- Vol. 23 (2) , 107-116
Effect of electroacupuncture on intestinal mucosal barrier function in functional dyspepsia rats based on TLR4/Myd88 pathway
- 22 February 2025
- Published by Springer Nature in Journal of Acupuncture and Tuina Science
- Vol. 23 (2) , 107-116
Effect of electroacupuncture on intestinal mucosal barrier function in functional dyspepsia rats based on TLR4/Myd88 pathway
- 29 October 2021
- Published by Wiley in The Anatomical Record
- Vol. 306 (12) , 2927-2938
Electroacupuncture restores intestinal mucosal barrier through TLR4/NF‐κB p65 pathway in functional dyspepsia‐like rats
Functional dyspepsia (FD) is a common functional gastrointestinal disorder with high morbidity. Electroacupuncture (EA) has been applied to treat FD for a long time. The aim of this study was to investigate the effects of EA and its mechanism about intestinal mucosal barrier in rodent model of FD. Male Sprague–Dawley rats were randomly divided into the control group and the model group. Then, the rats in model group were established to the FD model by multifactor interventions. In Experiment 1, qualified FD‐like rats were randomly divided into three groups: FD, EA, and acupuncture (AP) groups. The interventions of EA and AP lasted 14 days, food intake, and body weight were recorded every 5 days. In Experiment 2, qualified FD‐like rats were randomly divided into five groups: FD, EA, AP, EA + TAK242, and TAK242 groups. The interventions of EA and AP lasted 14 days, while TAK242 injection continued for 6 days. The rats were sacrificed for the measurement of serum Interleukin‐ 6 (IL‐6) and Tumor necrosis factor‐α (TNF‐α) assayed by ELISA. Western blotting was used to assess the expression of TLR4, Myd88, NF‐κB p65, p‐NF‐κB p65, TRAF6, ZO‐1, and occludin in the duodenum. The transmission electron microscope was used to observe the ultrastructure of intestinal epithelial cells. Compared with the rats in the group FD, the rats in EA group had significantly increase of body weight, food intake, and protein expressions of ZO‐1 and occludin, while expressions of TLR4, Myd88, NF‐κB p65, p‐NF‐κB p65, TRAF6 in the duodenum and IL‐6, and TNF‐α in serum were decreased. The EA + TAK242 treatment had similar effects to the EA treatment but with increased potency; compared with EA, AP showed similar but reduced effects. Our data demonstrated that EA is more effective than AP in improving intestine mucosal barrier. The possible mechanisms of EA may involve the TLR4/NF‐κB p65 pathway.
- 29 October 2021
- Published by Wiley in The Anatomical Record
- Vol. 306 (12) , 2927-2938
Electroacupuncture restores intestinal mucosal barrier through TLR4/NF‐κB p65 pathway in functional dyspepsia‐like rats
Functional dyspepsia (FD) is a common functional gastrointestinal disorder with high morbidity. Electroacupuncture (EA) has been applied to treat FD for a long time. The aim of this study was to investigate the effects of EA and its mechanism about intestinal mucosal barrier in rodent model of FD. Male Sprague–Dawley rats were randomly divided into the control group and the model group. Then, the rats in model group were established to the FD model by multifactor interventions. In Experiment 1, qualified FD‐like rats were randomly divided into three groups: FD, EA, and acupuncture (AP) groups. The interventions of EA and AP lasted 14 days, food intake, and body weight were recorded every 5 days. In Experiment 2, qualified FD‐like rats were randomly divided into five groups: FD, EA, AP, EA + TAK242, and TAK242 groups. The interventions of EA and AP lasted 14 days, while TAK242 injection continued for 6 days. The rats were sacrificed for the measurement of serum Interleukin‐ 6 (IL‐6) and Tumor necrosis factor‐α (TNF‐α) assayed by ELISA. Western blotting was used to assess the expression of TLR4, Myd88, NF‐κB p65, p‐NF‐κB p65, TRAF6, ZO‐1, and occludin in the duodenum. The transmission electron microscope was used to observe the ultrastructure of intestinal epithelial cells. Compared with the rats in the group FD, the rats in EA group had significantly increase of body weight, food intake, and protein expressions of ZO‐1 and occludin, while expressions of TLR4, Myd88, NF‐κB p65, p‐NF‐κB p65, TRAF6 in the duodenum and IL‐6, and TNF‐α in serum were decreased. The EA + TAK242 treatment had similar effects to the EA treatment but with increased potency; compared with EA, AP showed similar but reduced effects. Our data demonstrated that EA is more effective than AP in improving intestine mucosal barrier. The possible mechanisms of EA may involve the TLR4/NF‐κB p65 pathway.